BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29538158)

  • 1. End-of-life of implantable defibrillator: are we certain it should always be replaced?
    Stazi F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e116-e119. PubMed ID: 29538158
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The implantable cardioverter-defibrillator: An update.
    Miller JD; Yousuf O; Berger RD
    Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in implantable cardioverter-defibrillator therapy: Advancement beyond technology alone.
    Bhakta D; Foreman LD
    Trends Cardiovasc Med; 2015 Oct; 25(7):612-3. PubMed ID: 25776986
    [No Abstract]   [Full Text] [Related]  

  • 6. When to consider an implantable cardioverter defibrillator following myocardial infarction?
    Szwejkowski BR; Wright GA; Connelly DT; Gardner RS
    Heart; 2015 Dec; 101(24):1996-2000. PubMed ID: 26526420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
    Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centers for Medicare and Medicaid Services' Decision to Reconsider Coverage Indications for ICDs: Where to Now?
    Al-Khatib SM; Gillis AM; Curtis AB
    Circulation; 2018 Jan; 137(4):317-319. PubMed ID: 29070501
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of single- vs dual-coil implantable defibrillator leads: An observational analysis from the SIMPLE study.
    Neuzner J; Hohnloser SH; Kutyifa V; Glikson M; Dietze T; Mabo P; Vinolas X; Kautzner J; O'Hara G; Lawo T; Brachmann J; VanErven L; Gadler F; Appl U; Wang J; Connolly SJ; Healey JS
    J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1078-1085. PubMed ID: 30945798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications.
    Kawata H; Hirai T; Doukas D; Hirai R; Steinbrunner J; Wilson J; Noda T; Hsu J; Krummen D; Feld G; Wilber D; Santucci P; Birgersdotter-Green U
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):724-9. PubMed ID: 26915696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
    Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of inappropriate shocks in young people and how to avoid them.
    Upadhyay GA; Mela T; Singh JP
    Heart; 2012 Oct; 98(19):1457-66. PubMed ID: 22965797
    [No Abstract]   [Full Text] [Related]  

  • 13. Ongoing Risk of Ventricular Arrhythmias and All-Cause Mortality at Implantable Cardioverter Defibrillator Generator Change: A Systematic Review and Meta-Analysis.
    Yuyun MF; Erqou SA; Peralta AO; Hoffmeister PS; Yarmohammadi H; Echouffo-Tcheugui JB; Martin DT; Joseph J; Singh JP
    Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009139. PubMed ID: 33554611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Prevention of Sudden Cardiac Death Early Post-Myocardial Infarction: Root Cause Analysis for Implantable Cardioverter-Defibrillator Failure and Currently Available Options.
    Elayi CS; Charnigo RJ; Heron PM; Lee BK; Olgin JE
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630173
    [No Abstract]   [Full Text] [Related]  

  • 15. Implantable Defibrillator Timing Windows: When Coincidence Can Be Confusing.
    Jackson N; Viswanathan K; Cameron D; Nair K
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002876. PubMed ID: 26902146
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.
    Santharam S; Hudsmith L; Thorne S; Clift P; Marshall H; De Bono J
    Europace; 2017 Mar; 19(3):407-413. PubMed ID: 27234868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10-year follow-up of a patient affected by myotonic dystrophy type 1 with implantable cardioverter-defibrillator implanted for secondary prevention.
    De Ambroggi G; Ali H; Cappato R; Sansone VA; De Ambroggi L
    J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):150-152. PubMed ID: 31490228
    [No Abstract]   [Full Text] [Related]  

  • 19. Improve the prevention of sudden cardiac arrest in emerging countries: the Improve SCA clinical study design.
    Zhang S; Singh B; Rodriguez DA; Chasnoits AR; Hussin A; Ching CK; Huang D; Liu YB; Cerkvenik J; Willey S; Kim YH
    Europace; 2015 Nov; 17(11):1720-6. PubMed ID: 26037794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of chronic total coronary occlusion on long-term outcomes in implantable cardioverter-defibrillator recipients with ischaemic heart disease.
    Nishikawa T; Fujino M; Nakajima I; Asaumi Y; Kataoka Y; Anzai T; Kusano K; Noguchi T; Goto Y; Nishimura K; Miyamoto Y; Kiso K; Yasuda S
    Europace; 2017 Jul; 19(7):1153-1162. PubMed ID: 27738062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.